Abstract | INTRODUCTION AND AIM: Authors deducibled from retrospective analysis of patients data with Turner syndrome, who reached near adult height and from results of many multicentre study, that induction of puberty should be designed individually. They show, that estrogen therapy used in their earlier practice for growth promoting did not improve final height of patients. METHODS: The patients were assigned into three groups. The group 1. consisted of untreated patients, who had spontaneous puberty (n = 10). The group 2. consisted of patients, who received oxandrolone and estrogen (n = 18). The group 3. consisted of patients treated with growth hormone (n = 17). In those patients received growth hormone estrogen treatment was started at the age of 14.7 +/- 1.97 years. RESULTS: The final height or near adult height was 144.0 +/- 4.6 cm, 143.5 +/- 1.8 cm, and 154.2 +/- 7.0 cm in group 1, 2 and 3 respectively. The final height was not greater in the group 2. compared to that found in patients who developed spontaneous puberty (group 1.). CONCLUSION:
|
Authors | László Ságodi, Enikó Sólyom |
Journal | Orvosi hetilap
(Orv Hetil)
Vol. 144
Issue 12
Pg. 563-8
(Mar 23 2003)
ISSN: 0030-6002 [Print] Hungary |
Vernacular Title | Törekvéseink az ösztrogénterápia optimalizálására Turner-szindrómában. |
PMID | 12723527
(Publication Type: Clinical Trial, Controlled Clinical Trial, English Abstract, Journal Article)
|
Chemical References |
- Anabolic Agents
- Estrogens
- Oxandrolone
- Growth Hormone
|
Topics |
- Adolescent
- Anabolic Agents
(therapeutic use)
- Body Height
(drug effects)
- Child
- Estrogens
(therapeutic use)
- Female
- Growth Hormone
(therapeutic use)
- Humans
- Menarche
(drug effects)
- Oxandrolone
(therapeutic use)
- Puberty
(drug effects)
- Treatment Outcome
- Turner Syndrome
(drug therapy, physiopathology)
|